CVRx to present Barostim integration strategies at AAHFN Annual Meeting

CVRx to present Barostim integration strategies at AAHFN Annual Meeting
CVRx hosts Barostim session at AAHFN

CVRx is set to lead a session on integrating Barostim therapy into comprehensive heart failure programs at this week's AAHFN Annual Meeting.

The event, which will take place on Wednesday, June 24, will feature expert faculty sharing practical insights and real-world case studies. Attendees can expect to gain actionable knowledge about incorporating Barostim into clinical practice, with a focus on improving outcomes for heart failure patients.

CVRx recently achieved a milestone with the first Barostim implant at Huntsville Hospital, expanding device therapy options for heart failure. The company has also broadened Barostim therapy access for patients through a partnership with RWJBarnabas Health at Robert Wood Johnson University Hospital. These initiatives follow CVRx’s continued efforts to expand clinical use of its device.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.